Interpace Biosciences IDXG
OTC IDXG
$6.05 -0.20 (-3.20%)
At close: Nov 13, 2026 · 4:00 PM EST

Interpace Biosciences (IDXG) Current Deferred Tax Assets (2009 - 2025)

Updated

Interpace Biosciences' Current Deferred Tax Assets came in at $22.77 million for Q4 2018, compared with -$8.23 million a year earlier.

Analysis

Interpace Biosciences (IDXG) Current Deferred Tax Assets (2009 - 2025) Analysis & Trends

  • Going back by year, Current Deferred Tax Assets was -$8.23 million in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 105.29 Bn 103.13 Bn 17.03 Bn
2 Natera 46.06 Bn 41.68 Bn 513.47 Mn
3 Labcorp Holdings 30.09 Bn 28.19 Bn 1.11 Bn
4 Quest Diagnostics 28.58 Bn 26.66 Bn 1.04 Bn
5 Guardant Health 20.44 Bn 16.05 Bn 236.15 Mn
6 BrightSpring Health Services 14.16 Bn 11.04 Bn 518.55 Mn
7 Encompass Health 13.83 Bn 14.29 Bn 1.54 Bn
8 Tempus AI 12.69 Bn 9.84 Bn 266.70 Mn
9 Davita 11.06 Bn 9.92 Bn 1.13 Bn
10 Interpace Biosciences 167.59 Mn 158.32 Mn 5.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -9.77 Bn
Dec 31, 2024 -35.07 Bn
Dec 31, 2023 -38,654.00
Dec 31, 2022 -38,256.00
Dec 31, 2018 22.77 Mn
Dec 31, 2017 -8.23 Mn
Dec 31, 2016 -11,007.00
Dec 31, 2009 -3.79 Mn
API Access

Interpace Biosciences Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=IDXG&period=max&api_key=YOUR_API_KEY